Farther Finance Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Buy |
7,082
+6,032
| +574% | +$500K | 0.01% | 832 |
|
|
2025
Q1 | $82.1K | Buy |
1,050
+40
| +4% | +$3.13K | ﹤0.01% | 1641 |
|
|
2024
Q4 | $91K | Buy |
1,010
+10
| +1% | +$901 | ﹤0.01% | 1345 |
|
|
2024
Q3 | $98.8K | Sell |
1,000
-43
| -4% | -$4.25K | ﹤0.01% | 1307 |
|
|
2024
Q2 | $97K | Buy |
1,043
+43
| +4% | +$4K | ﹤0.01% | 1144 |
|
|
2024
Q1 | $93.9K | Buy |
1,000
+500
| +100% | +$46.9K | 0.01% | 965 |
|
|
2023
Q4 | $44.6K | Sell |
500
-130
| -21% | -$11.6K | ﹤0.01% | 1076 |
|
|
2023
Q3 | $46K | Hold |
630
| – | – | 0.01% | 798 |
|
|
2023
Q2 | $52.4K | Buy |
630
+130
| +26% | +$10.8K | 0.01% | 653 |
|
|
2023
Q1 | $38.1K | Buy |
500
+470
| +1,567% | +$35.8K | 0.01% | 690 |
|
|
2022
Q4 | $2.49K | Buy |
+30
| New | +$2.49K | ﹤0.01% | 1380 |
|